Model Informed Drug Development Approaches for Immunogenicity Assessments Workshop

Model Informed Drug Development Approaches for Immunogenicity Assessments Workshop

Medical Device Quality Management System Regulation Risk Management

FDA Expert Panel on Testosterone Replacement Therapy for Men

Conversations on Cancer – Perspectives on Cancer Care Decision-Making Among Older Adults

Model Informed Drug Development Approaches for Immunogenicity Assessments Workshop

FDA Direct: Removing Black Box Warnings for HRT (Part 2/2)

Good Clinical Practice & Pharmacovigilance Compliance Symposium | D3S07 – Q&A Discussion Panel

FDA Direct: Catching Up on Agency Reforms

Initiating the Removal of the “Black Box Warning” on Hormone Replacement Therapy

Medical Device Quality Management System Regulation Design and Development

Good Clinical Practice & Pharmacovigilance Compliance Symposium | D3S03-2 – Q&A Discussion Panel

FDA Direct: Removing Black Box Warnings for HRT (Part 1/2)

Public Meeting: Reauthorization of the Biosimilar User Fee Act

Good Clinical Practice & Pharmacovigilance Compliance Symposium | D3S06 - (PV): Regulatory Updates

FDA Direct: FDA Awards Six National Priority Vouchers

Good Clinical Practice & Pharmacovigilance Compliance Symposium | D3S05 - (PV): Future of...

GCP & Pharmacovigilance Compliance Symposium | D3S03-1 - (BE): Clinical Study Conduct

November 13, 2025: Pediatric Advisory Committee Meeting (PAC)

Good Clinical Practice & Pharmacovigilance Compliance Symposium | D3S04 - (PV): International...

Tobacco Products Scientific Advisory Committee Meeting, October 7, 2025